| |
| |
|
| Insider
Information: |
Gilman Alfred G |
| Relationship: |
Director |
| City: |
Dallas |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
57,199 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$49,981,758 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
57,199 |
|
|
| Total
Value |
$49,981,758 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2015-08-06 |
8,912 |
2003-09-11 |
0 |
Premium* |
|
|
Eli Lilly & Co |
LLY |
Director |
2013-11-29 |
48,287 |
2003-11-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2007-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,500 |
3,475 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2007-12-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
2,975 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2007-12-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
2,475 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2008-02-20 |
4 |
OE |
$7.91 |
$79,070 |
D/D |
10,000 |
12,475 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2008-11-28 |
4 |
A |
$32.13 |
$145,003 |
D/D |
4,513 |
22,189 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2008-12-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
11,475 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2008-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
17,475 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2008-12-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
11,475 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2009-01-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
11,475 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2009-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
13,475 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2009-01-21 |
4 |
OE |
$7.66 |
$76,600 |
D/D |
10,000 |
21,475 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2009-11-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
19,475 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2009-11-30 |
4 |
A |
$35.89 |
$144,996 |
D/D |
4,040 |
27,505 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2009-12-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,000 |
11,475 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2010-05-27 |
4 |
OE |
$25.43 |
$127,150 |
D/D |
5,000 |
16,475 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2010-05-27 |
4 |
D |
$27.92 |
$127,120 |
D/D |
(4,553) |
11,922 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2010-10-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,000 |
2,922 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2010-10-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
1,922 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2010-11-30 |
4 |
A |
$34.63 |
$144,996 |
D/D |
4,187 |
33,173 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2011-03-17 |
4 |
OE |
$18.80 |
$714,150 |
D/D |
30,000 |
20,820 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2011-03-17 |
4 |
D |
$38.92 |
$714,065 |
D/D |
(18,347) |
13,575 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2011-03-17 |
4 |
AS |
$38.97 |
$66,249 |
D/D |
(1,700) |
11,875 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2011-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
31,875 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2011-05-02 |
4 |
AS |
$50.68 |
$1,015,460 |
D/D |
(20,000) |
11,875 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2011-11-30 |
4 |
A |
$36.34 |
$144,997 |
D/D |
3,990 |
38,941 |
0 |
- |
|
72 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
